Dynavax Technologies saw the highest growth of 1.99% in patent filings in June and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Dynavax Technologies‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Dynavax Technologies has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 75% filings and 100% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Dynavax Technologies is filings its patents. Among the top granted patent authorities, Dynavax Technologies has 100% of its grants in United States(US).
Immatics could be the strongest competitor for Dynavax Technologies
In terms of grant share, Dynavax Technologies stands in fifth position among its competitors. Immatics and Dynavax Technologies secured the top positions according to recent patent publication data.
Patents related to rare diseases and Covid-19 lead Dynavax Technologies's portfolio
Dynavax Technologies has the highest number of patents in rare diseases followed by, Covid-19 and climate change. For rare diseases, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Severe acute respiratory syndrome (sars) related patents lead Dynavax Technologies portfolio followed by liver cancer, and tetanus
Dynavax Technologies has highest number of patents in severe acute respiratory syndrome (sars) followed by liver cancer, tetanus, systemic lupus erythematosus, and myasthenia gravis.
For comprehensive analysis of Dynavax Technologies's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
